Literature DB >> 17178278

What is the future of oncology? National Cancer Institute initiatives to improve research, development, and implementation in cancer prevention and treatment.

Ernest Hawk1, Jaye L Viner.   

Abstract

To improve the efficiency and effectiveness with which we bring novel cancer treatment and prevention strategies into routine clinical use, the National Cancer Institute has commissioned the Clinical Trials Working Group to restructure its activities related to clinical trials. A total of 22 initiatives have been developed and are being implemented under the rubrics of Coordination, Prioritization/Scientific Quality, Standardization, Operational Efficiency, and Integrated Management. A similar model was recently applied to the newly formed Translational Research Working Group, which will focus on more efficient translation of scientific discoveries arising from the laboratory, clinic, or population into early phase clinical testing.

Entities:  

Mesh:

Year:  2006        PMID: 17178278     DOI: 10.1053/j.seminoncol.2006.10.012

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  2 in total

Review 1.  Interdisciplinary, translational, and community-based participatory research: finding a common language to improve cancer research.

Authors:  James R Hebert; Heather M Brandt; Cheryl A Armstead; Swann A Adams; Susan E Steck
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-03-31       Impact factor: 4.254

2.  SKLB-163, a new benzothiazole-2-thiol derivative, exhibits potent anticancer activity by affecting RhoGDI/JNK-1 signaling pathway.

Authors:  X Peng; G Xie; Z Wang; H Lin; T Zhou; P Xiang; Y Jiang; S Yang; Y Wei; L Yu; Y Zhao
Journal:  Cell Death Dis       Date:  2014-03-27       Impact factor: 8.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.